financetom
Business
financetom
/
Business
/
Cooling The AI Revolution: Mercurity Fintech Launches Subsidiary Aifinity To Tackle Heat In Tech
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cooling The AI Revolution: Mercurity Fintech Launches Subsidiary Aifinity To Tackle Heat In Tech
Feb 19, 2025 4:10 AM

Mercurity Fintech Holding Inc. ( MFH ) shares are trading higher premarket on Wednesday after the company disclosed that it established a majority-owned subsidiary in Hong Kong, Aifinity Base Limited

Aifinity aims to produce advanced liquid cooling panels designed to enhance the efficiency and performance of AI infrastructure, high-performance computing (HPC), Nvidia chip-powered GPUs, and other high-performance AI accelerators.

By integrating cutting-edge liquid cooling technology with user-friendly components, Aifinity plans to produce cooling panels designed to dissipate the intense heat from modern AI computing. 

Looking ahead, Aifinity intends to expand beyond cooling panels into broader cooling solutions.

The company aims to tackle the rising challenge of heat management in advanced AI systems and intends to collaborate with top hardware manufacturers through its holding company’s network to create tailored cooling solutions for next-generation AI infrastructure. 

Lately, Mercury Fintech has been focusing on expanding into AI hardware intelligent manufacturing and advanced liquid cooling solutions.

In December, the company closed a private investment in public equity and garnered gross proceeds of around $10 million.

Consequently, last month, the company announced the pricing of another private investment in public equity (PIPE) financing to generate approximately $8.04 million in gross proceeds before fees and expenses.

Price Action: MFH shares are up 14% at $7.97 premarket at the last check Wednesday.

Read Next

Baidu’s Robotaxi Service Hits 1.1 Million Paid Rides In Q4, Expands To Hong Kong As 1st Operator Allowed To Test Autonomous Vehicles

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Synovus Financial Said to Mull Merger After Receiving Interest, Bloomberg Reports
--Synovus Financial Said to Mull Merger After Receiving Interest, Bloomberg Reports
Jul 22, 2025
02:03 PM EDT, 07/22/2025 (MT Newswires) -- Price: 58.98, Change: +3.45, Percent Change: +6.21 ...
Trump says US will charge 19% tariff on goods from Philippines
Trump says US will charge 19% tariff on goods from Philippines
Jul 22, 2025
By Andrea Shalal and Trevor Hunnicutt WASHINGTON (Reuters) -U.S. President Donald Trump on Tuesday announced a new 19% tariff rate for goods from the Philippines after what he called a beautiful visit by Philippine President Ferdinand Marcos Jr. to the White House, saying U.S. goods would pay zero tariffs. Trump posted the news on his Truth Social media platform after...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy
Jul 22, 2025
Sanofi SA ( SNY ) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in London, U.K. The acquisition brings an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), both respiratory viruses, and expands the capabilities in vaccine design and development with Vicebio’s ‘Molecular Clamp’ technology. The vaccine candidate complements Sanofi’s...
Copyright 2023-2026 - www.financetom.com All Rights Reserved